For the quarter ending 2025-12-31, PAHC had -$17,283K decrease in cash & cash equivalents over the period. $8,255K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income | 27,459 | 26,527 | 48,264 |
| Non-cash impairment charges | - | - | 5,328 |
| Depreciation and amortization | 12,891 | 12,830 | 45,605 |
| Amortization of debt issuance costs | 572 | 572 | 2,015 |
| Deferred income taxes | 3,838 | 2,171 | -4,879 |
| Foreign currency (gains) losses, net | 1,245 | 239 | -600 |
| Acquisition-related items | 839 | 1,117 | 5,679 |
| Stock-based compensation expense | 434 | 339 | 717 |
| Other | 351 | 474 | 1,643 |
| Accounts receivable, net | -2,333 | -11,366 | 55,208 |
| Inventories, net | 47,032 | 26,181 | 44,294 |
| Other current assets | -7,565 | 306 | 16,346 |
| Other assets | -271 | 105 | -1,572 |
| Accounts payable | 753 | -4,627 | 45,555 |
| Accrued expenses and other liabilities | 11,025 | -13,688 | 47,159 |
| Net cash provided by operating activities | 19,352 | 9,302 | 80,124 |
| Purchases of short-term investments | 11,522 | 12,504 | 14,000 |
| Maturities of short-term investments | 5,004 | 9,000 | 49,000 |
| Capital expenditures | 11,097 | 13,806 | 38,293 |
| Business acquisition, net of cash acquired | - | - | 286,529 |
| Other, net | -431 | 3,704 | -1,134 |
| Net cash used by investing activities | -17,184 | -21,014 | -288,688 |
| Revolving credit facility borrowings | 62,000 | 86,000 | 532,000 |
| Debt issuance costs | - | - | 10,377 |
| Revolving credit facility repayments | 70,000 | 58,000 | 621,000 |
| Proceeds from insurance premium financing and other short-term debt | - | - | 7,530 |
| Payments of long-term debt | 4,062 | 4,063 | 325,014 |
| Proceeds from long-term debt | - | - | 650,000 |
| Payments of insurance premium financing and other short-term debt | 2,054 | 2,738 | 6,556 |
| Dividends paid | 4,864 | 4,864 | 19,449 |
| Net cash (used) provided by financing activities | -18,980 | 16,335 | 207,134 |
| Effect of exchange rate changes on cash | -471 | 107 | -1,144 |
| Net decrease in cash and cash equivalents | -17,283 | 4,730 | -2,574 |
| Cash and cash equivalents at beginning of period | 72,769 | 68,039 | - |
| Cash and cash equivalents at end of period | 55,486 | 72,769 | - |
PHIBRO ANIMAL HEALTH CORP (PAHC)
PHIBRO ANIMAL HEALTH CORP (PAHC)